The development of a novel artificial heart valve with outstanding durability and safety has
remained a challenge since the first mechanical heart valve entered the market 65 years …

Transcatheter aortic valve replacement (TAVR) has emerged as a ground‐breaking,
minimally invasive alternative to traditional open‐heart surgery, primarily designed for …

Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) for a failing prosthesis is
an appealing alternative to redo surgical AVR. We utilized data from the US National …

The use of bioprosthetic valves for treating patients with severe valve disease has increased
over the last 2 decades, and, as a consequence, a growing number of patients with failing …

The objective of this report was to directly compare, by means of a systematic review and
meta-analysis, redo surgical aortic valve replacement (re-sAVR) with valve-in-valve …

Background Due to a considerable rise in bioprosthetic as opposed to mechanical valve
implantations, an increase of patients presenting with failing bioprosthetic surgical valves in …

Background Bioprosthetic aortic valve use has increased steadily according to The Society
of Thoracic Surgeons (STS) database analyses. One of the momentums toward this trend is …

With this Research Topic we aim to provide readers, clinicians, researchers, or developers,
a broad scientific and technological overview of the progress made from the various …

OBJECTIVES Several single-centre experiences have reported significant operative
mortality and morbidity after mitral valve surgery in redo scenarios (ReMVS). Several …

OBJECTIVES The aim of this study was to analyse the outcome of patients between 50 and
69 years of age undergoing biological or mechanical aortic valve replacement. METHODS …